A Q&A with Robin Feldman
Last month, four academics published a joint paper criticising the increasing levels of concentration in the pharmaceutical sector and raising concerns about how widespread industry practices like common ownership could impede proper merger reviews. GCR USA spoke with UC Hastings College of Law professor Robin Feldman, one of the study’s authors, about the implications of those findings.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10